Avadel pharmaceuticals provides corporate update and reports fourth quarter and full year 2021 financial results

Dublin, ireland, march 17, 2022 (globe newswire) -- avadel pharmaceuticals plc (nasdaq: avdl), a company focused on transforming medicines to transform lives, today provided a corporate update and announced its financial results for the fourth quarter and full year ended december 31, 2021.
AVDL Ratings Summary
AVDL Quant Ranking